Latest Insider Transactions at Advaxis, Inc. (ADXSD)
This section provides a real-time view of insider transactions for Advaxis, Inc. (ADXSD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Advaxis, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Advaxis, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 07
2024
|
Israel Biotech Fund I, L.P. Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
5,294,486
-10.46%
|
$5,294,486
$1.25 P/Share
|
|
Feb 07
2024
|
Israel Biotech Fund I, L.P. Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
27,847,159
+18.25%
|
$0
$0.4 P/Share
|
|
Oct 18
2023
|
Israel Biotech Fund I, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
1,317,716
+28.95%
|
-
|
|
Oct 18
2023
|
A Moon Growth Fund Limited Partnership > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
0
|
-
|
|
Jan 19
2023
|
David Sidransky Director |
BUY
Grant, award, or other acquisition
|
Indirect |
46
+50.0%
|
-
|
|
Oct 11
2017
|
Adage Capital Partners Gp, L.L.C. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
600,000
-12.77%
|
$2,400,000
$4.3 P/Share
|
|
Sep 26
2017
|
Adage Capital Partners Gp, L.L.C. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
300,000
-6.0%
|
$1,200,000
$4.0 P/Share
|
|
Sep 25
2017
|
Adage Capital Partners Gp, L.L.C. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
405,323
-7.5%
|
$1,621,292
$4.38 P/Share
|
|
Sep 22
2017
|
Adage Capital Partners Gp, L.L.C. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
534,000
-8.99%
|
$2,136,000
$4.68 P/Share
|